BMRN

NASDAQ · Biotechnology

Biomarin Pharmaceutical Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$60.85

+0.94 (+1.57%)

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 27 79%

Hold 7 21%

Sell 0 0%

Price Target

Analyst Price Target +107.8% upside

Low Target $89.21

Average Target $126.44

High Target $194.19

Current Price $60.85

Current
$60.85

Target
$126.44

$89.21 $126.44 avg $194.19

Scenario Analysis

Bear Case

$89.21

46.6%

Low target

Base Case

$126.44

+107.8%

Avg target

Bull Case

$194.19

+219.1%

High target

Risk/Reward

4.7x

Highly favorable

Price in Context

52-Week High

$66.28

-8.2% from high

52-Week Low

$49.26

+23.5% from low

50-Day SMA

$54.37

+11.9% vs SMA

200-Day SMA

$55.65

+9.3% vs SMA

RSI (14)

55.1

Neutral

Target vs 52W High

$126.44

+90.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+5.4%
AMGN Amgen Inc	Hold	43	49%	$190.87	-52.7%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+179.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-9.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-42.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-46.0%
BIIB Biogen Inc	Buy	44	64%	$91.45	-55.7%